tubulointerstitial nephritis models.
Introduction
Tubulointerstitial diseases, including tubulointerstitial nephritis, have a major impact on overall renal function and on the eventual prognosis of renal diseases. 1 The mechanism by which tubulointerstitial lesions develop remains unclear. Recent studies have revealed that the upregulation of cytokines is involved in the pathogenesis of experimental by electron microscopy. Human renal tubular antigen (RTE) was not detected by the indirect immunofluorescence method using specific antihuman RTE rabbit serum (a kind gift from Dr. Naruse 4 ), as previously described.
5
Renal biopsies were performed with the informed consent of the patient. We instituted combined therapy of oral prednisolone (15 mg daily) with cyclosporin (6 mg/kg per day) (Fig. 2) . These treatments improved both urinary protein excretion and serum levels of total protein. After the therapy, a rebiopsy specimen of the kidney revealed marked improvement of interstitial cell infiltration and tubulitis. We measured the urinary levels of the chemokines, interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF)/monocyte chemoattractant protein-1 (MCP-1), which are involved in both the recruitment and the activation of neutrophils 6 and monocytes, respectively, 7 by enzyme-linked immunosorbent assay (ELISA). Urinary IL-8 and MCAF/MCP-1 levels were standardized by the amount of creatinine in the urine. The elevated urinary IL-8 level of 84.7 pg/mg · creatinine (normal range, Ͻ0.2 pg/mg · creatinine) and the MCAF/MCP-1 level, of 178.0 pg/mg · creatinine (normal range, Ͻ0.4 pg/mg · creatinine) were found to be dramatically decreased during the patient's immunosuppressive therapy-induced convalescence to 0.4 pg/mg · creatinine and 1.6 pg/mg · creatinine, respectively. In contrast, plasma IL-8 was not detected (normal Ͻ16 pg/ml) and serum MCAF/MCP-1 was slightly high (93 pg/ml; normal, 66.1 Ϯ 15.5 pg/ml, mean Ϯ SEM). In addition, the elevated serum level of tumor necrosis factor-α (TNF-α; 218.8 pg/ml) was decreased to 36.7 pg/ml, detected by ELISA as previously described. 8 We found that in 13 other patients with membranous nephropathy, urinary levels of IL-8 were below detectable levels, and urinary MCAF/MCP-1 and serum TNF-α levels were not as high (4.0 Ϯ 0.1 pg/mg · creatinine and 2.7 Ϯ 2.5 pg/ml, respectively), as in the patient described. She has received prednisolone 10 mg for maintenance every other day and the proteinuria has never recurred.
Discussion
We reported here a patient with tubulointerstitial nephritis associated with membranous nephropathy with elevated levels of cytokines. Tubulointerstitial nephritis observed in membranous nephropathy is relatively rare. 9 This patient denied any history of drug usage or collagen diseases. Katz et al. 10 reported three patients with anti-tubular basement membrane antibody nephritis associated with membranous nephropathy. Although we did not evaluate anti-tubular basement membrane antibody in this patient, we did not find any deposition of IgG along tubular basement membrane or RTE in glomerular capillaries. Thus, the mechanism of the association of membranous nephropathy and tubulointerstitial nephritis remains to be investigated.
This study revealed elevated levels of urinary IL-8 and MCAF/MCP-1 in this patient with tubulointerstitial nephritis associated with membranous nephropathy. We did not detect high levels of IL-8 or MCAF/MCP-1 in patients with membranous nephropathy without interstitial nephritis. The most noticeable difference between this patient and the others was in the marked infiltration of mononuclear cells. Although we did not detect the cell sources of the cytokines IL-8 and MCAF/MCP-1, these data suggest that the upregulation of these chemokines was highly specific for the tubulointerstitial nephritis in this patient. In support of this notion, we have previously reported that MCAF/MCP-1 plays a pivotal role in tubulointerstitial damage and promotes renal dysfunction in human lupus IgA nephropathy, 11 and an experimental glomerulonephritis model. 12 Furthermore, we previously reported that infiltrating mononuclear cells, tubular epithelial cells, and endothelial cells of the peritubular capillaries were positive for IL-8 and MCAF/MCP-1 by immunohistochemical and in-situ hybridization analyses. 6, 7 Therefore, even though it is not clear at present whether these cytokines induce tubulointerstitial nephritis or whether tubulointerstitial nephritis lesions release these cytokines, or whether both of these phenomena occur, these results suggest that upregulation of these chemokines may be closely associated with the pathogenesis of tubulointerstitial lesions in this patient.
We found that TNF-α in the serum was also elevated in this patient. TNF-α plays a crucial role in the pathogenesis of interstitial lesions in membranous nephropathy. 13 Taken together, it appears that once tubular epithelial cells and interstitial infiltrates have been activated by some inflammatory process, IL-8, MCAF/MCP-1, and TNF-α promote the interstitial inflammatory process through the infiltration and activation of leukocytes.
Urinary and serum levels of these cytokines fell to lower levels during the patient's convalescence induced by glucocorticoid and cyclosporin. The efficacy of cyclosporin in the treatment of membranous nephropathy has been established 14 as judged by the improvement of the proteinuria. Although the precise mechanism of the effects of this combined therapy on membranous nephropathy and tubulointerstitial nephritis remains to be investigated, one believable mechanism may be the inhibition of cytokines, including IL-8, MCAF/MCP-1, and TNF-α. Since glucocorticoids decrease the level of TNF-α, the inducers of IL-8 and MCAF/MCP-1, 15 via inhibition of the activity of NFkB, 16 glucocorticoids may suppress these cytokines, thereby inhibiting the activation and infiltration of leukocytes. In addition, cyclosporin inhibits T-cell activation via a decrease in IL-2, 17 which may decrease cytokines produced by T cells directly, or may indirectly decrease these cytokines produced by other inflammatory cells via an inhibitory interaction by inactivated T cells. Cyclosporin enhances the barrier size-selection of the glomerular basement membrane, 14 which may lead to the improvement of proteinuria. Collectively, this combined therapy may be effective in membranous nephropathy and tubulointerstitial nephritis, possibly via the improvement of barrier size and via a direct and/or indirect decrease of cytokines, leading to the reduction of immune complex and the inhibition of leukocyte activation and infiltration.
In summary, these results suggest that the upregulation of cytokines may play an important role in the pathogenesis of tubulointerstitial nephritis and that combined therapy with oral prednisolone and cyclosporin is effective in tubulointerstitial nephritis and membranous nephropathy.
